The invention relates to novel proteins with TNF-alpha antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNF-alpha related disorders.

 
Web www.patentalert.com

> Cysteine variants of granulocyte colony-stimulating factor

~ 00362